A detailed history of Keybank National Association transactions in Eli Lilly & CO stock. As of the latest transaction made, Keybank National Association holds 161,337 shares of LLY stock, worth $122 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
161,337
Previous 152,269 5.96%
Holding current value
$122 Million
Previous $138 Million 3.68%
% of portfolio
0.56%
Previous 0.57%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$772.14 - $960.02 $7 Million - $8.71 Million
9,068 Added 5.96%
161,337 $143 Million
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $17.7 Million - $22.2 Million
24,441 Added 19.12%
152,269 $138 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $13.5 Million - $18 Million
22,739 Added 21.64%
127,828 $99.4 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $1.82 Million - $2.14 Million
-3,458 Reduced 3.19%
105,089 $61.3 Million
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $734,208 - $1.01 Million
1,689 Added 1.58%
108,547 $58.3 Million
Q2 2023

Aug 01, 2023

BUY
$350.74 - $468.98 $585,034 - $782,258
1,668 Added 1.59%
106,858 $50.1 Million
Q1 2023

May 10, 2023

SELL
$310.63 - $364.82 $253,163 - $297,328
-815 Reduced 0.77%
105,190 $36.1 Million
Q4 2022

Jan 31, 2023

SELL
$321.55 - $374.67 $1.41 Million - $1.64 Million
-4,372 Reduced 3.96%
106,005 $38.8 Million
Q3 2022

Oct 27, 2022

BUY
$296.48 - $337.87 $1 Million - $1.15 Million
3,389 Added 3.17%
110,377 $35.7 Million
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $428,686 - $503,341
-1,538 Reduced 1.42%
106,988 $34.7 Million
Q1 2022

Apr 28, 2022

SELL
$234.69 - $291.66 $460,461 - $572,236
-1,962 Reduced 1.78%
108,526 $31.1 Million
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $20,686 - $25,671
92 Added 0.08%
110,488 $30.5 Million
Q3 2021

Nov 08, 2021

BUY
$221.6 - $272.71 $334,837 - $412,064
1,511 Added 1.39%
110,396 $25.5 Million
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $580,287 - $750,597
-3,214 Reduced 2.87%
108,885 $25 Million
Q1 2021

May 07, 2021

SELL
$164.32 - $212.72 $409,649 - $530,310
-2,493 Reduced 2.18%
112,099 $20.9 Million
Q4 2020

Feb 09, 2021

SELL
$130.46 - $172.63 $730,445 - $966,555
-5,599 Reduced 4.66%
114,592 $19.3 Million
Q3 2020

Oct 29, 2020

BUY
$146.22 - $169.13 $391,284 - $452,591
2,676 Added 2.28%
120,191 $17.8 Million
Q2 2020

Aug 10, 2020

SELL
$136.42 - $164.18 $368,333 - $443,286
-2,700 Reduced 2.25%
117,515 $19.3 Million
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $211,075 - $261,251
-1,773 Reduced 1.45%
120,215 $16.7 Million
Q4 2019

Feb 05, 2020

SELL
$106.92 - $132.43 $242,601 - $300,483
-2,269 Reduced 1.83%
121,988 $16 Million
Q3 2019

Nov 04, 2019

SELL
$106.79 - $116.16 $1.01 Million - $1.1 Million
-9,480 Reduced 7.09%
124,257 $13.9 Million
Q2 2019

Aug 01, 2019

SELL
$110.79 - $129.32 $481,160 - $561,636
-4,343 Reduced 3.15%
133,737 $14.8 Million
Q1 2019

May 08, 2019

SELL
$111.31 - $131.02 $574,136 - $675,801
-5,158 Reduced 3.6%
138,080 $17.9 Million
Q4 2018

Jan 30, 2019

SELL
$105.9 - $118.64 $355,400 - $398,155
-3,356 Reduced 2.29%
143,238 $16.6 Million
Q3 2018

Nov 08, 2018

SELL
$85.86 - $107.31 $755,739 - $944,542
-8,802 Reduced 5.66%
146,594 $15.7 Million
Q2 2018

Aug 08, 2018

SELL
$75.7 - $86.88 $1.15 Million - $1.32 Million
-15,136 Reduced 8.88%
155,396 $13.3 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $1.04 Million - $1.23 Million
-14,076 Reduced 7.62%
170,532 $13.2 Million
Q4 2017

Feb 08, 2018

SELL
$81.94 - $87.89 $2.53 Million - $2.72 Million
-30,900 Reduced 14.34%
184,608 $15.6 Million
Q3 2017

Nov 02, 2017

SELL
$77.07 - $85.54 $49,556 - $55,002
-643 Reduced 0.3%
215,508 $18.4 Million
Q2 2017

May 14, 2018

BUY
N/A
47,963 Added 28.52%
216,151 $17.8 Million
Q1 2017

May 14, 2018

SELL
N/A
-9,232 Reduced 5.2%
168,188 $14.1 Million
Q4 2016

May 14, 2018

BUY
N/A
177,420
177,420 $13 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.